Aribex Revenue and Competitors
Estimated Revenue & Valuation
- Aribex's estimated annual revenue is currently $8.3M per year.
- Aribex's estimated revenue per employee is $251,000
Employee Data
- Aribex has 33 Employees.
Aribex Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $9.8M | 39 | 3% | N/A | N/A |
#2 | $15.1M | 60 | 7% | N/A | N/A |
#3 | $6M | 24 | 0% | N/A | N/A |
#4 | $24.8M | 99 | -12% | N/A | N/A |
#5 | $19.3M | 77 | 8% | N/A | N/A |
#6 | $28.1M | 112 | 20% | N/A | N/A |
#7 | $3.8M | 15 | -46% | N/A | N/A |
#8 | $19.3M | 77 | 4% | N/A | N/A |
#9 | $45.4M | 181 | 4% | N/A | N/A |
#10 | $6.8M | 27 | N/A | N/A | N/A |
What Is Aribex?
Aribex, Inc. has quickly become recognized as the worldwide leader in innovative handheld X-ray products. Aribex is a privately owned, Orem, Utah-based company founded in 2003 with the mission to develop, manufacture, and market new technologies in the X-ray radiography fields. Aribex flagship products are the NOMAD and NOMAD Pro handheld X-ray systems. The NOMAD battery-powered handheld platform provides for expansion from dentistry into other X-ray imaging solutions such as veterinary, medical, industrial, and security applications. For more information, visit http://www.aribex.com
keywords:N/A
N/A
Total Funding
33
Number of Employees
$8.3M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Aribex News
... Forecast Period From 2022 to 2028: Air Techniques, Allengers Medical Systems, ARDET Dental & Medical Devices, Aribex Inc, ASAHI Roentg.
... Carestream Health, Hologic, Inc., MinXray, Inc, Aribex and Shimadzu among other domestic and global players. Report's key features:.
... Market 2022 Industry Challenges by Players Air Techniques, Allengers Medical Systems, ARDET Dental & Medical Devices, Aribex Inc.
Other Companies in Charlotte
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $4M | 33 | -30% | N/A |
#2 | $5.8M | 33 | -20% | N/A |
#3 | $8.1M | 33 | -8% | N/A |
#4 | $6M | 33 | -52% | N/A |
#5 | $7.1M | 33 | -11% | N/A |